The main clinical, genetic, epilepsy, EEG, and brain MRI features of CSNK2B-related pharmacoresistant epilepsy and the biphasic pattern of epilepsy are summarized in Tables 1, 2. The gene discussed is CSNK2B; the disease is epilepsy.